NCT07002983 Motor Control Retraining Exercises on Shoulder Dysfunction Post Mastectomy
| NCT ID | NCT07002983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Post Mastectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-05-05 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Motor control and strengthening exercises can improve function in shoulder impingement patients by realigning the scapula and changing muscle recruitment patterns. Peripheral musculoskeletal impairments can be associated with cortical reorganisation. Movement retraining using the principles of motor control retrain muscle recruitment patterns and improve scapular kinematics, reducing subacromial impingement, thus improving function and reducing pain. Furthermore, the need of this study is developed from the lack in the quantitative knowledge and information in the published studies about the effect of motor control retraining exercises on shoulder dysfunction post-mastectomy.
Eligibility Criteria
Inclusion Criteria: * The subject selection will be according to the following criteria: * Female patients with age range between 40-55 years. * All patients have shoulder dysfunction. * Patients were 2 months to 4 months post modified radical mastectomy or axillary lymph node dissection. * Patients received their radiotherapy or chemotherapy or both. Exclusion Criteria: * The potential participants will be excluded if they meet one of the following criteria: * Rheumatoid arthritis. * History of trauma or accidental injuries. * Neurological involvement (stroke, Parkinsonism). * History of surgery on involved shoulder. * Diabetic patient. * Moderate and severe lymphoedema.
Contact & Investigator
Esraa Tarek, PhD
PRINCIPAL INVESTIGATOR
Teaching assistant physical therapy for surgery cairo university
Frequently Asked Questions
Who can join the NCT07002983 clinical trial?
This trial is open to female participants only, aged 40 Years or older, up to 55 Years, studying Post Mastectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07002983 currently recruiting?
Yes, NCT07002983 is actively recruiting participants. Contact the research team at esraatarek94@gmail.com for enrollment information.
Where is the NCT07002983 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07002983 clinical trial?
NCT07002983 is sponsored by Cairo University. The principal investigator is Esraa Tarek, PhD at Teaching assistant physical therapy for surgery cairo university. The trial plans to enroll 60 participants.